Gene silencing shows promise for treating two fatal neurological disorders
12/04/2017
NIH-funded preclinical studies suggest designer drug may treat ALS and spinocerebellar ataxia 2.
NIH-funded preclinical studies suggest designer drug may treat ALS and spinocerebellar ataxia 2.